Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 19/74 ]
NASDAQ | Common Stock
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.
Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.
The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors.
Profound Medical Corp. is headquartered in Mississauga, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 7, 24 | -0.38 Decreased by -46.15% | -0.30 Decreased by -26.67% |
| Aug 8, 24 | -0.28 Increased by +20.00% | -0.29 Increased by +3.45% |
| May 9, 24 | -0.26 Increased by +18.75% | -0.30 Increased by +13.33% |
| Mar 7, 24 | -0.42 Increased by +8.70% | -0.32 Decreased by -31.25% |
| Nov 2, 23 | -0.26 Decreased by -8.33% | -0.33 Increased by +21.21% |
| Aug 9, 23 | -0.35 Decreased by -25.00% | -0.34 Decreased by -2.94% |
| May 10, 23 | -0.32 Increased by +20.00% | -0.34 Increased by +5.88% |
| Mar 7, 23 | -0.46 Increased by +6.12% | -0.36 Decreased by -27.78% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 2.83 M Increased by +37.17% | -9.36 M Decreased by -2.28% | Decreased by -330.65% Increased by +25.44% |
| Jun 30, 24 | 2.23 M Increased by +39.36% | -6.92 M Increased by +5.93% | Decreased by -309.92% Increased by +32.50% |
| Mar 31, 24 | 2.23 M Increased by +20.03% | -6.92 M Decreased by -2.62% | Decreased by -309.85% Increased by +14.50% |
| Dec 31, 23 | 1.90 M Increased by +51.27% | -6.17 M Increased by +35.22% | Decreased by -324.55% Increased by +57.18% |
| Sep 30, 23 | 2.06 M Increased by +1.45% | -9.16 M Decreased by -83.21% | Decreased by -443.45% Decreased by -80.59% |
| Jun 30, 23 | 1.60 M Decreased by -20.89% | -7.36 M Decreased by -24.03% | Decreased by -459.11% Decreased by -56.78% |
| Mar 31, 23 | 1.86 M Increased by +36.36% | -6.74 M Increased by +17.94% | Decreased by -362.42% Increased by +39.82% |
| Dec 31, 22 | 1.26 M Increased by +25.95% | -9.53 M Increased by +6.24% | Decreased by -757.92% Increased by +25.56% |